Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 3/20 | 0.41 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.41 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.41 |
| ▸ | ELANE | P08246 | 2/20 | 0.41 |
| ▸ | F2RL3 | Q96RI0 | 2/20 | 0.39 |
| ▸ | HTR3A | P46098 | 1/20 | 0.38 |
| ▸ | LMNA | P02545 | 1/20 | 0.37 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.37 |
| ▸ | THRB | P10828 | 1/20 | 0.37 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.37 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.37 |
| ▸ | PIK3CG | P48736 | 1/20 | 0.37 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.36 |
| ▸ | POLB | P06746 | 2/20 | 0.34 |
| ▸ | NR4A2 | P43354 | 1/20 | 0.34 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.34 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.33 |
| ▸ | TSHR | P16473 | 3/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2489345 | 0.83 | ALDH1A1 (0.46) | HSD17B10KDM4ESMN1; SMN2ALDH1A1HPGD | |
| SCHEMBL13279633 | 0.79 | SMN1; SMN2 (0.43) | MAPTKDM4EHTR3ALMNACYP1A2 | |
| SCHEMBL20298203 | 0.79 | BACE1 (0.46) | MAPTHSD17B10KDM4EHIF1AELANE | |
| SCHEMBL10984833 | 0.79 | LMNA (0.43) | MAPTHTR3ALMNACYP1A2THRB | |
| SCHEMBL288842 | 0.79 | HTR3A (0.36) | MAPTELANEHTR3ALMNACYP1A2 | |
| SCHEMBL24814788 | 0.79 | HTR3A (0.36) | MAPTELANEHTR3ALMNACYP1A2 | |
| SCHEMBL288843 | 0.79 | ALDH1A1 (0.43) | MAPTKDM4EELANEF2RL3HTR3A | |
| SCHEMBL1041204 | 0.79 | PLAU (0.46) | MAPTHSD17B10HIF1AF2RL3HTR3A | |
| SCHEMBL9390262 | 0.79 | ELANE (0.39) | MAPTHSD17B10KDM4EHIF1AELANE | |
| SCHEMBL28435873 | 0.79 | ELANE (0.39) | MAPTHSD17B10KDM4EHIF1AELANE |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 81 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119553384-A | Preparation method of antistatic modified nylon filament | 广东金狮新材科技有限公司 | 2025-03-04 | — | — | CN | claimed |
| CN-117810644-B | Polyimide lithium ion battery diaphragm and preparation method thereof | 深圳市博盛新材料有限公司 | 2024-04-26 | — | — | CN | claimed |
| CN-117810644-A | Polyimide lithium ion battery diaphragm and preparation method thereof | 深圳市博盛新材料有限公司 | 2024-04-02 | — | — | CN | claimed |
| CN-112384546-B | Thermally conductive resin composition | 东洋纺株式会社 | 2024-01-16 | — | — | CN | claimed |
| CN-113943262-B | Preparation method of 2-aminobenzoxazole compound | 烟台海川化学制品有限公司 | 2022-10-14 | — | — | CN | claimed |
| US-20040077515-A1 | Bis-triazinylaminobenzoxazole derivatives | CIBA SPECIALTY CHEMICALS CORP. | 2004-04-22 | — | — | US | claimed |
| EP-1368347-A1 | BIS-TRIAZINYLAMINOBENZOXAZOLE DERIVATIVES | Ciba SC Holding AG (CH) | 2003-12-10 | — | — | EP | claimed |
| WO-2002066474-A1 | BIS-TRIAZINYLAMINOBENZOXAZOLE DERIVATIVES | CIBA SPECIALTY CHEMICALS HOLDING INC. (CH) | 2002-08-29 | — | — | WO | claimed |
| EP-0789723-B1 | POLYAMIC ACIDS AND METHODS TO CONVERT POLYAMIC ACIDS INTO POLYIMIDEBENZOXAZOLE FILMS | MICHIGAN MOLECULAR INST (US) | 2001-12-05 | — | — | EP | claimed |
| US-5985969-A | REACTION PRODUCT OF PYROMELLITIC DIANHYDRIDE AND DIAMINO BENZOXAZOLE WITH CHAIN EXTENDERS FOR COATING ON SUBSTRATES | THE DOW CHEMICAL COMPANY (US) | 1999-11-16 | — | — | US | claimed |
| US-5919892-A | CYCLIZED TO POLYIMIDEBENZOXAZOLE | THE DOW CHEMICAL COMPANY (US) | 1999-07-06 | — | — | US | claimed |
| US-5741585-A | Polyamic acid precursors and methods for preparing higher molecular weight polyamic acids and polyimidebenzoxazole | THE DOW CHEMICAL COMPANY (US) | 1998-04-21 | — | — | US | claimed |
| EP-0822954-A1 | POLYAMIC ACID PRECURSORS AND METHOD FOR PREPARING POLYIMIDEBENZOXAZOLE | THE DOW CHEMICAL COMPANY (US) | 1998-02-11 | — | — | EP | claimed |
| EP-0789723-A1 | POLYAMIC ACIDS AND METHODS TO CONVERT POLYAMIC ACIDS INTO POLYIMIDEBENZOXAZOLE FILMS | THE DOW CHEMICAL COMPANY (US) | 1997-08-20 | — | — | EP | claimed |
| WO-1996034033-A1 | POLYAMIC ACID PRECURSORS AND METHOD FOR PREPARING POLYIMIDEBENZOXAZOLE | THE DOW CHEMICAL COMPANY (US) | 1996-10-31 | — | — | WO | claimed |
| WO-1996013541-A1 | POLYAMIC ACIDS AND METHODS TO CONVERT POLYAMIC ACIDS INTO POLYIMIDEBENZOXAZOLE FILMS | THE DOW CHEMICAL COMPANY (US) | 1996-05-09 | — | — | WO | claimed |
| JP-6056992-A | — | — | None | — | — | JP | disclosed |
| US-20260117026-A1 | DIELECTRIC MATERIALS BASED ON HETEROAROMATIC-EXTENDED BISMALEIMIDES | MERCK PATENT GMBH (DE) | 2026-04-30 | — | — | US | disclosed |
| EP-0026474-B1 | COMPOSITION AND PROCESS FOR OXIDATIVE DYEING OF HAIR | Wella Aktiengesellschaft (DE) | 1983-06-08 | — | — | EP | disclosed |
| JP-H00656992-A | — | — | 0001-01-01 | — | — | JP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040077515-A1 | Bis-triazinylaminobenzoxazole derivatives | FOS, FBL, WDR1 | MAPT 3895/4885HSD17B10 2718/4885KDM4E 2163/4885 |
| US-20260117026-A1 | DIELECTRIC MATERIALS BASED ON HETEROAROMATIC-EXTENDED BISMALEIMIDES | KCNE1, GLRB, PBRM1 | MAPT 2622/4885HSD17B10 4058/4885KDM4E 90/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.